Testosterone transdermal - Ardana

Drug Profile

Testosterone transdermal - Ardana

Alternative Names: ARD 0403; Testo Bi-gel; Testo Cream

Latest Information Update: 17 Oct 2008

Price : $50

At a glance

  • Originator Ardana Bioscience
  • Developer Ardana plc
  • Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Eye disorder therapies; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Hypogonadism; Unspecified

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 18 Mar 2008 Pharmacokinetics data from a Phase-I trial in surgically menopausal women released by Ardana
  • 04 Dec 2007 Transdermal testosterone cream is available for partnering in the US and other regions (http://www.ardana.co.uk)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top